ALDX
Price
$5.51
Change
-$0.23 (-4.01%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
330.85M
37 days until earnings call
CANF
Price
$0.62
Change
-$0.00 (-0.00%)
Updated
Oct 6, 04:57 PM (EDT)
Capitalization
14.25M
Interact to see
Advertisement

ALDX vs CANF

Header iconALDX vs CANF Comparison
Open Charts ALDX vs CANFBanner chart's image
Aldeyra Therapeutics
Price$5.51
Change-$0.23 (-4.01%)
Volume$6.27K
Capitalization330.85M
Can-Fite BioPharma
Price$0.62
Change-$0.00 (-0.00%)
Volume$5K
Capitalization14.25M
ALDX vs CANF Comparison Chart in %
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. CANF commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Buy and CANF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (ALDX: $5.51 vs. CANF: $0.62)
Brand notoriety: ALDX and CANF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 89% vs. CANF: 190%
Market capitalization -- ALDX: $330.85M vs. CANF: $14.25M
ALDX [@Biotechnology] is valued at $330.85M. CANF’s [@Biotechnology] market capitalization is $14.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileCANF’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • CANF’s FA Score: 1 green, 4 red.
According to our system of comparison, ALDX is a better buy in the long-term than CANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while CANF’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 6 bearish.
  • CANF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CANF is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а +5.76% price change this week, while CANF (@Biotechnology) price change was +0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($331M) has a higher market cap than CANF($14.3M). ALDX YTD gains are higher at: 10.421 vs. CANF (-61.945). CANF has higher annual earnings (EBITDA): -8.91M vs. ALDX (-48.46M). ALDX has more cash in the bank: 81.9M vs. CANF (6.46M). CANF has less debt than ALDX: CANF (90K) vs ALDX (15.6M). CANF has higher revenues than ALDX: CANF (560K) vs ALDX (0).
ALDXCANFALDX / CANF
Capitalization331M14.3M2,315%
EBITDA-48.46M-8.91M544%
Gain YTD10.421-61.945-17%
P/E RatioN/AN/A-
Revenue0560K-
Total Cash81.9M6.46M1,269%
Total Debt15.6M90K17,333%
FUNDAMENTALS RATINGS
ALDX vs CANF: Fundamental Ratings
ALDX
CANF
OUTLOOK RATING
1..100
2152
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3894
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANF's Valuation (25) in the Biotechnology industry is in the same range as ALDX (40). This means that CANF’s stock grew similarly to ALDX’s over the last 12 months.

CANF's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALDX (100). This means that CANF’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's SMR Rating (98) in the Biotechnology industry is in the same range as CANF (100). This means that ALDX’s stock grew similarly to CANF’s over the last 12 months.

ALDX's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for CANF (94). This means that ALDX’s stock grew somewhat faster than CANF’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CANF (100). This means that ALDX’s stock grew similarly to CANF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCANF
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 28 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FWONA99.332.95
+3.06%
Liberty Media Corp
LARK26.56-0.14
-0.52%
Landmark Bancorp
AXL6.16-0.06
-0.96%
American Axle & Manufacturing Holdings
LVLU4.94-0.12
-2.47%
Lulu's Fashion Lounge Holdings Inc
MPW5.40-0.14
-2.53%
Medical Properties Trust

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.01%
CANF - ALDX
46%
Loosely correlated
-0.26%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
+0.86%
PLRX - ALDX
38%
Loosely correlated
-1.97%
ARVN - ALDX
37%
Loosely correlated
+0.10%
More

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
-0.26%
ALDX - CANF
46%
Loosely correlated
-4.01%
OABI - CANF
31%
Poorly correlated
+3.07%
NEVPF - CANF
30%
Poorly correlated
N/A
TPST - CANF
27%
Poorly correlated
+4.23%
ORMP - CANF
26%
Poorly correlated
+0.41%
More